1-10 of 10
Chelsea D Mullins
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Prospective Multicenter Study of Minimal Residual Disease Assessment Using a Next-Generation Immunosequencing Assay and CT Monitoring for Surveillance after Frontline Treatment in Diffuse Large B-Cell Lymphoma

Anita Kumar, Jason R. Westin, Stephen J. Schuster, Grzegorz S. Nowakowski, Izidore S. Lossos, Devin Copley, Clare Grieve, Allison P. Jacob, Ashlee Joseph, Leana Laraque, Gita Masand, Chelsea D Mullins, Ellen Napier, Tania Rodriguez, Venkatraman Seshan, Shreya Vemuri, Andrew D. Zelenetz
Journal: Blood
Blood (2021) 138 (Supplement 1): 52.
https://doi.org/10.1182/blood-2021-150572
Published: 2021
Journal Articles

Frontline Sequential Immunochemotherapy Plus Lenalidomide for Mantle Cell Lymphoma Incorporating MRD Evaluation: Phase II, Investigator-Initiated, Single-Center Study

Zachary D. Epstein-Peterson, MD, Connie Lee Batlevi, MDPhD, Philip Caron, MD PhD, Ahmet Dogan, MD PhD, Pamela Drullinsky, MD, John Gerecitano, MD PhD, Audrey Hamilton, MD, Paul A. Hamlin, MD, Caleb Ho, MD, Allison P. Jacob, Leana Laraque, BA, Matthew J Matasar, MD, Alison J. Moskowitz, MD, Craig H. Moskowitz, MD, Chelsea D Mullins, BS, Colette Owens, MD, Gilles Salles, Heiko Schöder, MD, David J. Straus, MD, Anas Younes, Andrew D Zelenetz, MD PhD, Anita Kumar, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–12.
https://doi.org/10.1182/blood-2020-136565
Published: 2020
Journal Articles

Cerebrospinal Fluid (CSF) Analysis of Tumor-Specific Cell-Free DNA (cfDNA) As a Diagnostic and Prognostic Tool for Central Nervous System (CNS) Invasion in Lymphoma

Adam J Olszewski, MD, Anna D Chorzalska, PhD, Max Petersen, Thomas A Ollila, MD, Adam Zayac, MD, Habibe Kurt, MD, Diana O Treaba, MD, John L Reagan, MD, Andrew Hsu, MD, Pamela C Egan, MD, James Butera, MD, William Rafelson, MDMBA, Rabin Niroula, MBBS, John Vatkevich, Jordan Robison, CRA, Ilyas Sahin, MD, Chelsea D Mullins, BS, Patrycja M Dubielecka, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 21–22.
https://doi.org/10.1182/blood-2020-134757
Published: 2020
Journal Articles

Interim Analysis from a Prospective Multicenter Study of Next-Generation Sequencing Minimal Residual Disease Assessment and CT Monitoring for Surveillance after Frontline Treatment in Diffuse Large B-Cell Lymphoma

Anita Kumar, MD, Jason Westin, MD, Stephen J Schuster, MD, Grzegorz S. Nowakowski, MD, Izidore S. Lossos, MD, Connie Lee Batlevi, MDPhD, Philip Caron, MD PhD, Pamela Drullinsky, MD, John Gerecitano, MD PhD, Audrey Hamilton, MD, Paul A. Hamlin, MD, Steven M. Horwitz, MD, Allison P. Jacob, Erel Joffe, MD MSc, Ashlee Joseph, Gottfried R. von Keudell, MD PhD, Leana Laraque, BA, Oscar B Lahoud, MD, Matthew J Matasar, MD, Craig H. Moskowitz, MD, Chelsea D Mullins, BS, Ariela Noy, MD, Colette Owens, MD, Maria Lia Palomba, Carol S. Portlock, MD, Ildefonso Rodriguez-Rivera, MD, Gilles Salles, MDPhD, Venkatraman Seshan, PhD, David J. Straus, MD, Shreya Vemuri, Anas Younes, Andrew D Zelenetz, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–47.
https://doi.org/10.1182/blood-2020-138889
Published: 2020
Journal Articles

Detectable Circulating Tumor DNA 28 Days after the CD19 CAR T-Cell Therapy, Axicabtagene Ciloleucel, Is Associated with Poor Outcomes in Patients with Diffuse Large B-Cell Lymphoma

Matthew J. Frank, MD PhD, Nasheed Hossain, MD, Ali Bukhari, MD, Erin Dean, MD, Jay Y. Spiegel, MDFRCPC, Gursharan K. Claire, MPH, Ilan M. Kirsch, Allison P. Jacob, Chelsea D Mullins, BS, Lik Wee Lee, PhD, Katherine A. Kong, Juliana Craig, BA, Crystal L. Mackall, MD, Aaron P. Rapoport, Saurabh Dahiya, MD, Frederick L. Locke, MD, David B Miklos, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 884.
https://doi.org/10.1182/blood-2019-132057
Published: 2019
Journal Articles

Tumor-Specific Cell-Free DNA (cfDNA) in the Cerebrospinal Fluid (CSF) Detects Cytologically Occult Central Nervous System (CNS) Involvement in Aggressive Lymphomas

Adam J Olszewski, MD, Anna D Chorzalska, PhD, Diana O Treaba, MD, John L Reagan, MD, Pamela C Egan, MD, Habibe Kurt, MD, James Butera, MD, William Rafelson, MDMBA, Alexander C Mohler, MD MS, Thomas A Ollila, MD, Rabin Niroula, MBBS, Jordan Robison, CRA, Chelsea D Mullins, BS, Patrycja M Dubielecka, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2800.
https://doi.org/10.1182/blood-2019-125475
Published: 2019
Journal Articles

Whole Genome Sequencing Reveals Novel Recurring Somatic Mutations Affecting HUWE1 and DIAPH2 Genes in Multiple Myeloma

Michael H. Tomasson, MD, Dong Shen, PhD, Vishwanathan Hucthagowder, PhD, William Schierding, B.S., Chelsea D. Mullins, BSci, Mark Fiala, BS, CCRP, Ira M Hall, PhD, John Wallis, PhD, Robert S. Fulton, Lucinda A. Fulton, MS, Shashikant Kulkarni, PhD, Elaine R. Mardis, PhD, Richard K Wilson, Timothy J. Ley, John F. DiPersio, MD, PhD, Christopher A. Maher, PhD, Ravi Vij, MD, Li Ding
Journal: Blood
Blood (2012) 120 (21): 320.
https://doi.org/10.1182/blood.V120.21.320.320
Published: 2012
Journal Articles

Activation of K-Ras in Arf-Null Mice Is Not Sufficient for Malignant Transformation of Post-Germinal Center B-Cells

Chelsea D. Mullins, BSci, Mack Y. Su, Vishwanathan Hucthagowder, PhD, Liang Chu, PhD, Lan Lu, MSci, Shashikant Kulkarni, PhD, Ravi Vij, MD, Michael H. Tomasson, MD
Journal: Blood
Blood (2012) 120 (21): 5016.
https://doi.org/10.1182/blood.V120.21.5016.5016
Published: 2012
Journal Articles

Germinal Center Specific Activation of K-Ras, Common In Multiple Myeloma, Is Selected Against and Is Not Sufficient to Initiate Plasma Cell Transformation In Mice

Chelsea D. Mullins, BSci, Michael Tomasson, MD, Lan Lu, MSci, Mack Y. Su, Vishwanathan Hutchagowder, PhD, Ravi Vij, MBBS, MD, Shashikant Kulkarni, PhD, Liang Chu, PhD
Journal: Blood
Blood (2010) 116 (21): 137.
https://doi.org/10.1182/blood.V116.21.137.137
Published: 2010
Journal Articles

Resequencing Analysis of the Human Candidate Ras and Receptor Tyrosine Kinase Gene Family In Multiple Myeloma

Vishwanathan Hucthagowder, PhD, Chelsea D. Mullins, BSci, Rekha Meyer, PhD, Rakesh Nagarajan, MD, PhD, John F. DiPersio, MD, PhD, Ravi Vij, MBBS, MD, Michael H. Tomasson, MD, Shashikant Kulkarni, PhD, FACMG
Journal: Blood
Blood (2010) 116 (21): 301.
https://doi.org/10.1182/blood.V116.21.301.301
Published: 2010